Kadcyla

Product: KADCYLA

Manufacturer: ROCHE

Generic: Trastuzumab Emtansine Injection

Type: Injection

Strength: Kadcyla 100 / 160 mg Injection

Packing: 1 Injection in 1 vial

Description: It is used to treat Breast Cancer which have spread to other organs and have not responded to other cancer medicines.

Indication: Breast cancer

Use of Kadcyla 100 / 160 mg Injection

This injection is an anti-cancer medicine that binds to HER2 receptors on breast cancer cells and flags the cancer cells for destruction by the body’s immune system.

Side Effects of the Kadcyla 100 / 160 mg Injection

Major & minor side effects for Kadcyla 100 / 160 mg Injection

• Infections
• Decrease in blood cell count
• Headache
• Depression
• Dizziness
• Heart Rhythm disorders
• Abdominal pain
• Skin Reactions
• Injection site reactions
• Musculoskeletal (bone, muscle or joint) pain
• Bleeding
• Low blood platelets
• Headache
• Liver disorder
• Constipation
• Nosebleeds

When not to use?

This injection is not suggested for use in patients with a known allergy to Trastuzumab Emtansine or any other inactive ingredients present along with it.

Warning

• Pregnancy
  This injection is unsafe to use during pregnancy as it causes fetal risk like life-threatening situations. For further details seek advice from your doctor.
• Breast-feeding
  During Breast-feeding this injection is probably unsafe as the drug could represent a significant risk to the baby.
• Alcohol
  There is no data available. For further details seek advice from your doctor.
• Driving
  Injection does not usually affect your ability to drive. For further details seek advice from your doctor.
• Kidney
  There is limited information available on the use of Kadcyla 100 mg Injection in patients with kidney disease. For further details seek advice from your doctor.
• Liver
  Kadcyla 100 mg Injection should be used with caution in patients with severe liver disease. Dose adjustment of Kadcyla 100 mg Injection may be needed. For further details seek advice from your doctor.